Chengdu University of TCM
Chengdu, Sichuan, 610075, China
NCT Number: NCT01687660
Hypothesis: Acupuncture obtains an abiding effect on migraine prophylaxis Design: A open-label randomized controlled trial. 249 participants will be included. Three arms: acupuncture in acupoint-meridian, non-acupoint-meridian group, and waiting list.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Chengdu, Sichuan, 610075, China
Aim: to attest the abiding efficacy and safety of acupuncture for migraine prophylaxis Design: A open-label randomized controlled trial will be performed in Chengdu, Hunan and Chongqing province. Two hundred and forty-three participants will be randomly assign to acupoint-meridian group, non-acupoint-meridian group, and wait-and-see group. Each participants will receive 20 sessions of acupuncture in 4 weeks, with a duration of 30 minutes in a session. After all the treatments was accomplished, there will be 5 times follow-ups in the impending every 4 weeks. The primary outcome is frequency of migraine attacks 16 weeks after inclusion. Secondary outcomes include frequency of migraine attacks at the 4th and 24th week, headache severity, MSQ(Migraine Specific Quality of Life Questionnaire MSQ Version2.1), etc.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
:
apply acupuncture to prevent the migraine attack
Time frame: 16th week after inclusion
to assess the frequency of migraine attacks at the 16th week after inclusion
Time frame: 4th and 24th week after inclusion
to assess the frequency of migraine attacks at the 4th and 24th week respectively
Time frame: 0 day, 4th, 8th, 12th, 16th, 20th, 24th week after inclusion
to evaluate the change of severity of headache
Time frame: the day of inclusion and 4th week after inclusion
to observe the change of MSQ
Time frame: 1 day
an outcome to indicate the expectation of patient towards acupuncture treatment for migraine
Li ying
Other
A Continuous Study on Abiding Effect of Acupuncture for Migraine Treatment
Acronym: AMP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06409845
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial DetailsNCT05903040
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial DetailsNCT04853797
Brain Diseases, Central Nervous System Diseases
Glostrup, Region Sjælland, Denmark
View Trial DetailsNCT05211050
Brain Diseases, Central Nervous System Diseases
Glostrup, Region Sjælland, Denmark
View Trial Details